Salmonella enterica serotype Typhimurium elicits an acute inflammatory response in the intestinal mucosa of humans that can be modeled using streptomycin-pretreated mice (
2). This inflammatory reaction is initiated by direct contact of serotype Typhimurium with host cells, such as epithelial cells, macrophages, or dendritic cells, followed by an amplification of inflammatory responses in tissue (
31). Responses that are effectively amplified in tissue give rise to the most prominent changes in gene expression observed in the intestinal mucosa during serotype Typhimurium infection, including markedly increased mRNA levels of gamma interferon (IFN-γ [
Ifn-γ gene]), interleukin-17 (IL-17 [
Il-17 gene]), and IL-22 (
Il-22 gene) (
9,
24,
25). T cells play an important role in amplifying inflammatory responses in the cecal mucosa, because depletion of CD3
+ cells causes in a dramatic reduction in cecal inflammation and neutrophil recruitment (
9). T-cell depletion also results in a markedly blunted induction of
Ifn-γ,
Il-17, and
Il-22 in the intestinal mucosa during serotype Typhimurium infection (
9,
25). IL-17 and IL-22 help to orchestrate intestinal inflammation by inducing the production of neutrophil chemoattractants (e.g., keratinocyte-derived cytokine [KC] or IL-8), dendritic cell chemoattractants (e.g., CCL20), and antimicrobials (e.g., Lipocalin-2 and iNOS) in the mucosa (
9,
25,
42). However, the mechanisms by which T-cell-dependent amplification of responses to serotype Typhimurium infection is initiated in the intestinal mucosa have not been explored experimentally.
In other models of infection, cytokines released by macrophages or dendritic cells have been implicated in stimulating cytokine production by T cells. For example, detection of bacterial flagellin by cytosolic pattern recognition receptors in macrophages activates caspase 1, resulting in the release of mature IL-18 (
6,
20,
21,
34). IL-18 can stimulate antigen experienced T cells to rapidly secrete IFN-γ during bacterial infection by an antigen-independent mechanism, thereby significantly amplifying early effector responses in vivo (
32). In a mouse model of
Klebsiella pneumoniae lung infection, bacterial stimulation of Toll-like receptor 4 (TLR4) on dendritic cells results in IL-23 production (
13). IL-23 in turn triggers the rapid production of IL-17 and IL-22 by T cells (
1,
12), which is required for efficient neutrophil recruitment in this model (
39,
40). IL-23 has also been implicated in enhancing inflammatory responses elicited by other bacterial pathogens, including
Citrobacter rodentium,
Pseudomonas aeruginosa,
Mycoplasma pneumoniae, and
Mycobacterium bovis (
5,
36,
38,
42). The goal of the present study was to determine whether IL-23 contributes to an amplification of inflammatory responses in the cecal mucosa during serotype Typhimurium infection of streptomycin-pretreated mice.
MATERIALS AND METHODS
Bacterial strains and culture conditions.
Serotype Typhimurium strain IR715 is a fully virulent, nalidixic acid-resistant derivative of isolate ATCC 14028 and was used in all experiments (
33). Bacteria were cultured aerobically at 37°C in Luria-Bertani (LB) broth.
Animal experiments.
Mice deficient in p19 (IL-23p19−/− mice) were generated by breeding B6.129S5-Il23p19tm1Lex mice with C57BL/6 mice under specific-pathogen-free conditions in a barrier facility. IL-23p19−/− mice and wild-type littermates were bred and genotyped at the Mutant Mouse Regional Resource Center at the University of California, Davis. Mice deficient for Tcd, the gene encoding the δ T-cell receptor chain, were obtained from the Jackson Laboratory (B6.129P2-Tcrdtm1Mom/J).
To study inflammation in the cecum, streptomycin-pretreated mice were orally infected with serotype Typhimurium as described previously (
2). In brief, mice were inoculated with streptomycin (0.1 ml of a 200-mg/ml solution in sterile water) intragastrically. IL-23p19
−/− mice (
n = 16) and wild-type littermates (
n = 9) were inoculated intragastrically 24 h later with bacteria (0.1 ml containing approximately 5 × 10
8 CFU). As a control, IL-23 p19
−/− mice (
n = 6) and wild-type littermates (
n = 8) were inoculated with 0.1 ml of sterile LB broth (mock infection).
Trd−/
− (
n = 6) and wild-type C57/B6 (
n = 5) mice were infected as described above with serotype Typhimurium. As a control, wild-type (
n = 6) and
Trd−/
− mice (
n = 4) were inoculated with 0.1 ml of LB broth (mock infection). At 48 h after infection, mice were euthanized, and samples of the cecum collected for isolation of mRNA and for histopathological analysis. For bacteriologic analysis, cecal contents and Peyer's patches were homogenized, and serial 10-fold dilutions were spread on agar plates containing the appropriate antibiotics. For isolation of intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) from infected mice, three groups of two 8- to 10-week-old mice (C57BL/6; Jackson Laboratory) were inoculated with streptomycin (0.1 ml of a 200-mg/ml solution in sterile water) intragastrically. After 24 h, the mice were inoculated with bacteria (0.1 ml containing approximately 5 × 10
8 CFU). IEL and LPL were isolated 48 h postinfection.
Real-time PCR.
For analysis of the changes in gene expression after serotype Typhimurium infection in the mouse cecum, tissue samples were collected and immediately snap-frozen in liquid nitrogen at the site of surgery and stored at −80
οC until processing. RNA was then extracted from snap-frozen tissue with TriReagent (Molecular Research Center) according to the instructions of the manufacturer. Next, 1 μg from each sample was reverse transcribed in 50 μl of TaqMan reverse transcription reagent (Applied Biosystems), and 4 μl of cDNA was used for each real-time reaction. Real-time PCR was performed using Sybr green (Applied Biosystems) and the 7900HT fast real-time PCR system. The data were analyzed by using a comparative threshold cycle method (Applied Biosystems). Increases in cytokine expression in infected mice were calculated relative to the average level of the respective cytokine in eight mock-infected wild-type mice. A list of genes analyzed in the present study with the respective primers is provided in Table
1.
For analysis of absolute copy number expression for Il-17 and Reg3g (the gene encoding regenerating islet-derived 3 gamma), real-time PCR was performed using 1 μl of cDNA (as described above) for each reaction in a temperature cycler equipped with a fluorescence detection monitor (LightCycler; Roche Diagnostics, Mannheim, Germany). Thus, cDNA corresponding to 20 ng of RNA served as a template in a 10-μl reaction containing 4 mM MgCl2, 0.5 μM concentrations of each primer, and 1× LightCycler-Fast Start DNA Master Sybr Green I mix (Roche Diagnostics). A negative control reaction without cDNA template was included with each set of reaction to check for possible contamination. The PCR conditions were as follows: initial denaturation at 95°C for 10 min, followed by 45 cycles of 95°C for 15 s, annealing at 60°C for 5 s, and extension at 72°C for 10 s. The cycle-to-cycle fluorescence emission was monitored at 530 nm and analyzed by using LightCycler software. Gene-specific plasmid standards were included with every set of reactions, and standard curves generated for each gene product were used to quantify the expression of Il-17 and Reg3g. All reactions were run in duplicate, and the intersample variation was <10%.
Histopathology.
Tissue samples were fixed in formalin, processed according to standard procedures for paraffin embedding, sectioned at 5 μm, and stained with hematoxylin and eosin. A veterinary pathologist scored inflammatory changes using a blind-sample analysis. Neutrophil counts were determined per high (×400)-magnification microscopy, and numbers were averaged from 10 microscopic fields for each animal.
Isolation of intestinal lymphocytes.
IEL and LPL were isolated from C57BL/6 mice by standard procedures (
4,
19,
30). Briefly, three groups of two naive mice and three groups of two serotype Typhimurium-infected mice were euthanized, and organs from each group of mice were combined. Intestines were removed beginning from the duodenum and ending at the proximal colon. Intestines were dissected by removing the remaining mesentery and vasculature. Each segment was then opened longitudinally, the luminal content was removed, and the tissue was cut into ∼5-mm sections with a scalpel. The sections were subsequently washed in cold 1× Hanks balanced salt solution (HBSS; Gibco catalog no. 14185) containing 0.015 M HEPES (Gibco catalog no.15630) a total of six times to remove mucus and remaining fecal matter.
For IEL isolation, tissue was placed and stirred for 15 min at room temperature in prewarmed (37°C) 1× HBSS containing 10% fetal bovine serum (Gibco catalog no. 10082), 0.015 M HEPES, and 5 mM EDTA and stirred for 15 min 37°C, followed by three 15-min washes with buffer adjusted to room temperature. The supernatant from each wash was pooled and poured through a nylon wool column to enrich for T cells and remove mucus. The resulting cell suspension was used to analyze IEL.
To isolate LPL, the tissue remaining after IEL isolation was stirred in prewarmed (37°C) 1× RPMI (Sigma catalog no. R1145) containing 10% fetal bovine serum, penicillin-streptomycin (Gibco catalog no.15240-062), 0.015 M HEPES, and 1.6 mg of collagenase (Sigma-Aldrich catalog no. C6885)/ml for 45 min in a 37°C incubator. The resulting cell suspension was washed twice with 1× HBSS containing 0.015 M HEPES, enriched for T cells using a nylon wool column, and used to analyze LPL.
Flow cytometry.
The IEL and LPL suspensions containing approximately 4 × 106 cells each were resuspended in cold phosphate-buffered saline and stained with Aqua Live/Dead cell discriminator (Invitrogen catalog no. L34597) according to the manufacturer's protocol. Cells were then stained for 1 h in the dark at 4°C with optimized concentrations of anti-CD3 Alexa750-APC (eBioscience clone 17A2), anti-CD8 Alexa700 (eBioscience clone 53-6.7), anti-CD4 Pacific Blue (eBioscience clone RM4-5), anti-TCR GD R-PE (BD Pharmingen clone GL3), and biotinylated polyclonal anti-IL-23R (BAF1686; R&D Systems). Cells were washed twice with PBS containing 1% bovine serum albumin (fluorescence-activated cell sorting [FACS] buffer). Cells were then stained for 1 h with streptavidin-conjugated Qdot 605 (Q10101MP; Invitrogen). Stained cells were washed once in FACS buffer and subsequently fixed in 4% formalin for 1 h. Cells were then washed once and resuspended in FACS buffer and analyzed using an LSR II flow cytometer (Becton Dickinson, San Jose, CA). The data were analyzed by using FlowJo software (Treestar, Inc., Ashland, OR). Gates were set on singlets and then on live lymphocytes. Subsequent gates were based on Fluorescence-Minus-One and unstained controls.
Statistical analysis.
Fold changes in mRNA levels measured by real-time PCR underwent logarithmic transformation, and percentage values underwent angular transformation prior to analysis by Student t test.
DISCUSSION
Acute intestinal inflammation characterized by a massive neutrophil influx is a hallmark of serotype Typhimurium infection (
27,
35,
41). However, the precise mechanisms by which this host response is orchestrated in tissue have not been fully worked out. We have recently shown that depletion of CD3
+ lymphocytes markedly reduces the ability of mice to recruit neutrophils into the cecal mucosa and to produce KC, IFN-γ, IL-22, and IL-17, which are among the most prominently induced cytokines in serotype Typhimurium-infected tissue (
9). These data suggest that T cells are an important component of mechanisms that help to amplify inflammatory responses to serotype Typhimurium infection in the intestinal mucosa. However, little is known about how serotype Typhimurium infection initiates these T- cell-dependent amplification mechanisms. We show here that diverse subsets of T cells in the intestinal mucosa express the receptor for IL-23, a cytokine important for initiating the production of KC, REG3γ, IL-22, and IL-17 in response to serotype Typhimurium infection. IFN-γ production was not affected by IL-23 deficiency, suggesting that the early expression of this important cytokine by T cells (i.e., at 2 days after infection) is triggered through other pathways, perhaps involving IL-12 or IL-18 production. For example, IL-18 has recently been implicated in amplifying inflammatory responses early after serotype Typhimurium infection in the spleens of mice by triggering IFN-γ production in antigen experienced CD4 T cells by an antigen-independent mechanism (
32).
Two important questions arise from the results of our study. First, which intestinal T-cell subsets contribute to IL-17 and IL-22 production during serotype Typhimurium infection? In the lung mucosa, γδ T cells have been implicated as an important source of IL-17 during
Mycobacterium tuberculosis and
M. bovis infection (
18,
22,
36). Similarly, injection of
Escherichia coli into the peritoneal cavity of naive mice triggers IL-23 production in a TLR4 signaling-dependent manner, and the resulting IL-17 production originates largely from γδ T cells (
28). Our results suggest that γδ T cells are also one of the cellular sources of IL-17 in the serotype Typhimurium-infected mouse. However, γδ T-cell-deficient mice were still able to produce
Il-17 mRNA, albeit at reduced levels, during serotype Typhimurium infection, suggesting that additional cell types contributed to production of this cytokine in the inflamed cecum. In addition to γδ T cells, the receptor for IL-23 was expressed predominantly by CD3
+ CD4
− CD8
− γδ
− cells (NKT cells and/or CD4
− CD8
− T cells) in the intestinal epithelium and by CD4
+ T cells and CD3
+ CD4
− CD8
− γδ
− cells in the lamina propria. Each of these cell types has been implicated as a source of IL-17 production in different animal models of inflammation (
3,
13,
16,
17,
23,
25). A distinct subset of CD4
− NKT cells produces IL-17, contributing to infiltration of neutrophils in a galactosylceramide-induced model of airway inflammation (
17). NKT cells constitutively express IL-23 receptor and rapidly produce IL-17 upon stimulation with IL-23 (
23). IL-17 mRNA has been shown to be specifically expressed by a subset of murine CD4
− CD8
− T cells (
16). In contrast, IL-17 is mainly derived from CD4
+ T cells during
M. pneumoniae lung infection (
38). Both CD4
+ T cells and CD8
+ T cells are a source of IL-17 during infection of mice with
Helicobacter pylori (
3) or
K. pneumoniae (
13). Finally, depletion of memory CD4
+ T cells by simian immunodeficiency virus blunts IL-17 responses elicited early (i.e., 5 h) after serotype Typhimurium infection of the ileal mucosa in rhesus macaques (
25), pointing to an innate induction of these T-cell responses. Thus, T
H17 cells contribute to IL-17 production in the ileal mucosa of a relevant animal species.
The second question arising from the present study relates to the mechanisms that initiate IL-23 production during serotype Typhimurium infection. Electron microscopic analysis of serotype Typhimurium infection shows that all bacteria detected in the intestinal mucosa have an intracellular location, either within mononuclear phagocytes (macrophages and/or dendritic cells) or within neutrophils (
7,
26). Since only a very small fraction of cells in infected tissue contain bacteria, the total capacity for cytokine production by these cells may be limited in scope. However, macrophages and dendritic cells infected with serotype Typhimurium are a potential source of IL-23, and our data suggest that this cytokine helps to amplify a subset of inflammatory responses in tissue. During
K. pneumoniae infection, release of IL-23 by dendritic cells in the lung mucosa is triggered through stimulation of TLR4 by lipopolysaccharide (
13). Similarly, production of IL-23 by murine bone marrow-derived dendritic cells in response to
S. enterica serotype Enteritidis infection is TLR4 dependent (
29). However, CD11c
+ CX3CR1
+ mucosal dendritic cells do not generate MyD88-dependent responses in the ceca of serotype Typhimurium-infected mice (
10), suggesting that the signals produced at mucosal sites are not mimicked adequately by bone marrow-derived cells. A recent finding that points to macrophages as possible sources of IL-23 is the observation that the inflamed human intestine contains a unique subset of CD14
+ intestinal macrophages, which produces larger amounts of IL-23 than the resident CD14
− macrophages (
14). Alternatively, serotype Typhimurium may stimulate mucosal dendritic cells or mucosal macrophages to produce IL-23 through MyD88-independent mechanisms, which have been proposed to contribute to cecal inflammation (
11). One possible MyD88-independent mechanism leading to IL-23 production by dendritic cells is the activation of the intracellular bacterial sensor NOD2. IL-23 produced by this NOD2-dependent, MyD88-independent mechanism results in IL-17 production in human memory T cells (
37). However, additional work is needed to understand the precise mechanisms by which the IL-23/IL-17 axis is triggered in the intestinal mucosa during serotype Typhimurium infection.
Acknowledgments
We thank Sebastian Winter, Maria Winter, and Sean-Paul Nuccio for their help with the animal experiments. We also thank Monica Macal and Carol Oxford for their input in designing the flow cytometry panels.
This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR12088-01 from the National Center for Research Resources, National Institutes of Health. Work in A.J.B.'s laboratory was supported by Public Health Service grants AI040124, AI044170, and AI079173. T.A.P. and R.L.S. are recipients of fellowships from the Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasília, Brazil. I.G. was supported by Public Health Service grant AI060555.